Clinical progression of breast cancer malignant behavior: what to expect and when to expect it.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Oncology

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2000.18.3.591PMID 10653874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis

  2004cited by this paper
• Aging, progression, and phenotype in breast cancer.

  1998cited by this paper
• The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.

  1998cited by this paper
• Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.

  1997cited by this paper
• Darwin's clinical relevance

  1997cited by this paper
• Breast cancer metastatic phenotype as predicted by histologic tumor markers.

  1997cited by this paper
• Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.

  1996cited by this paper
• Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

  1996cited by this paper
• Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.

  1995cited by this paper
• Karnofsky Memorial Lecture. Natural history of small breast cancers.

  1994cited by this paper
• Breast cancer screening with mammography: overview of Swedish randomised trials.

  1993cited by this paper
• Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.

  1993cited by this paper
• Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

  1992cited by this paper
• Update of the Swedish two-county program of mammographic screening for breast cancer.

  1992cited by this paper
• Canadian National Breast Screening Study.

  1990cited by this paper
• A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

  1989cited by this paper
• Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial.

  1988cited by this paper
• Observations on survival curve analysis with particular reference to breast cancer treatment

  1986cited by this paper
• Staging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy.

  1982cited by this paper
• Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

  1980cited by this paper
• On the diagnosis and treatment of breast cancer.

  1979cited by this paper
• Curability of breast cancer.

  1977cited by this paper
• Long‐term followup of breast cancer patients: The 30‐year report

  1974cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• I. The Results of Radical Operations for the Cure of Carcinoma of the Breast.

  1907cited by this paper
• I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

  1894cited by this paper

• A stochastic modelling framework for cancer patient trajectories: combining tumour growth, metastasis, and survival

  2025cites this paper
• Long-term efficacy of CDK4/6 inhibitors in early HR+, HER2- high-risk breast cancer: An updated systematic review and meta-analysis

  2025cites this paper
• Metastasis from the tumor interior and necrotic core formation are regulated by breast cancer-derived angiopoietin-like 7

  2023cites this paper
• Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer

  2021cites this paper
• Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database.

  2021cites this paper
• Correlation between P53 Arg72Pro and MDM4 gene rs4245739 polymorphisms in breast cancer

  2020cites this paper
• The chromatin remodeling protein BRM regulates the transcription of tight junction proteins: Implication in breast cancer metastasis.

  2019cites this paper
• Modulating p300 acetylation promotes the rapid degradation of ERBB2 mRNA in ERBB2-positive breast cancer cells.

  2019cites this paper
• SPHINGOSINE KINASE 1 REGULATES FASCIN EXPRESSION TO PROMOTE METASTASIS IN TRIPLE NEGATIVE BREAST CANCER

  2018cites this paper
• THE ROLES OF CHEMOKINES AND CHEMOKINE RECEPTORS IN TUMOR METASTASIS

  2017cites this paper
• Time‐dependent risk and predictors of venous thromboembolism in breast cancer patients: A population‐based cohort study

  2017cites this paper
• Antiproliferative activity of Zanthoxylum tetraspermum W.A. stem bark extract against Breast carcinoma in mice

  2016cites this paper
• Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.

  2016cites this paper
• Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases

  2016cites this paper
• Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

  2016cites this paper
• CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression

  2016cites this paper
• TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk.

  2015cites this paper
• An individual reference limit for 'early' diagnosis of metastatic breast cancer during postoperative follow-up.

  2015cites this paper
• ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.

  2015cites this paper
• Disease Progression: Local and Distal Spread (Mechanisms)

  2015cites this paper
• Delay in diagnosis amongst carcinoma lung patients presenting at a tertiary respiratory centre

  2014cites this paper
• Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation

  2014cites this paper
• Clinical cancer research: the past, present and the future

  2014cites this paper
• THERAPEUTIC EFFECTS OF ZANTHOXYLUM TETRASPERMUM W.A. STEM BARK ON CARBOHYDRATE METABOLIZING ENZYMES IN MAMMARY CARCINOMA MICE

  2014cites this paper
• MUC2 mRNA detection in peripheral blood and bone marrow of breast cancer patients reveals micrometastasis

  2013cites this paper
• A simple and reproducible prognostic index in luminal ER-positive breast cancers

  2013cites this paper
• Local and regular recurrences in breast cancer and Paget´s disease of the breast

  2013cites this paper
• ast cancer p atients reveals

  2013cites this paper
• Multifocal breast cancer documented in large‐format histology sections

  2013cites this paper
• Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers

  2013cites this paper
• Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy

  2013cites this paper
• MUC 2 mRNA detection in periphera marrow of bre micrometastasis

  2013cites this paper
• Regulation and action of SKP2 and RhoA in cell and tumor models: Investigation into the molecular mechanisms responsible for the aggressive phenotype of triple-negative breast cancer

  2013cites this paper
• X-ray enabled detection and eradication of circulating tumor cells with nanoparticles.

  2012cites this paper
• X-ray Radiation Enabled Cancer Detection And Treatment With Nanoparticles

  2012cites this paper
• ANÁLISE DA VARIAÇÃO DO NÚMERO DE CÓPIAS DOS GENES DA VIA PI3K/AKT EM TUMORES DE MAMA TRIPLO NEGATIVOS

  2012cites this paper
• Characterization of the BTB/POZ protein ZBTB4 as a transcriptional regulator of cyclin D1

  2012cites this paper
• Oncolytic herpes simplex virus treatment of metastatic breast cancer.

  2011cites this paper
• An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype

  2011cites this paper
• Factores pronósticos en pacientes con cáncer de mama sin afectación ganglionar axilar

  2011cites this paper
• Avaliação de fatores prognósticos em tumores de mama nos estádios IIA e IIIB e sua correlação com sobrevida

  2010cites this paper
• Analyzing the biological role of the Transcription Factor Kaiso in Breast Tumourigenesis

  2010cites this paper
• The Role of Radiotherapy in Breast Cancer Management

  2010cites this paper
• Neoadjuvant Oncolytic Virus Therapy in a Murine Model of Cancer Surgery

  2010cites this paper
• Clinicopathological significance of calreticulin in breast invasive ductal carcinoma

  2010cites this paper
• Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness

  2010cites this paper
• Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.

  2010cites this paper
• Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.

  2009cites this paper
• Molecular mechanisms controlling E-cadherin expression in breast cancer.

  2009cites this paper
• No evidence of familial correlation in breast cancer metastasis

  2009cites this paper
• Molecular markers of breast axillary lymph node metastasis

  2009cites this paper
• Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes

  2008cites this paper
• Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

  2008cites this paper
• Mechanisms of metastasis

  2008cites this paper
• Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

  2008cites this paper
• Human Breast Tumor Cells Express Multimodal Imaging Reporter Genes

  2008cites this paper
• Population-based family studies: Genetic contribution to cancer development and survival?

  2008cites this paper
• Lung metastasis genes couple breast tumor size and metastatic spread

  2007cites this paper
• Axillary surgery in breast cancer patients

  2007cites this paper
• Conventional and new emerging prognostic factors in breast cancer: an update.

  2007cites this paper
• Serial transplantation of NMU‐induced rat mammary tumors: A model of human breast cancer progression

  2007cites this paper
• Molecular signatures predict outcomes of breast cancer.

  2006cites this paper
• Heterogeneity of Invasive Ductal Carcinoma: Proposal for a Hypothetical Classification

  2006cites this paper
• Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression.

  2006cites this paper
• Functional Characterization of Two Novel Human Prostate Cancer Metastasis Related Genes

  2006cites this paper
• Ascertaining Prognosis for Breast Cancer in Node‐Negative Patients with Innovative Survival Analysis

  2006cites this paper
• Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.

  2006cites this paper
• Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness.

  2006cites this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cites this paper
• Taxanos en el tratamiento adyuvante del cáncer de mama con ganglios positivos: metanálisis

  2005cites this paper
• Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis

  2005cites this paper
• Does the number of lymph nodes examined in patients with lymph node‐negative breast carcinoma have prognostic significance?

  2005cites this paper
• Voltage-Gated Sodium Channel Expression and Potentiation of Human Breast Cancer Metastasis

  2005cites this paper
• Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells

  2005cites this paper
• 2005 Highlights From: Controversies in Breast Cancer Adjuvant and Neoadjuvant Therapy; New York, NY September 2005

  2005cites this paper
• Genes that mediate breast cancer metastasis to lung

  2005cites this paper
• Does postmastectomy radiation reduce mortality in women with stage T1–2 node-positive breast cancer?

  2005cites this paper
• Controversies in the therapy of early stage breast cancer.

  2005cites this paper
• [Taxanes in the adjuvant therapy of breastcancer with positive nodes: a meta-analysis].

  2005cites this paper
• Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

  2005cites this paper
• Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.

  2005cites this paper
• The natural history of breast carcinoma in the elderly

  2004cites this paper
• Host genetics and tumour metastasis

  2004cites this paper
• Genetic, Genomic, and Bioinformatic Tools for Studying Breast Cancer Progression

  2004cites this paper
• Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247

  2004cites this paper
• The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse.

  2004cites this paper
• Duration of Signs and Survival in Premenopausal Women with Breast Cancer

  2004cites this paper
• Obstructive jaundice in a metastatic tumor of the pancreas from breast cancer: a case report.

  2003cites this paper
• Prognostic Significance of Laminin, Laminin Receptor, and Bone Marrow Micrometastases in Breast Cancer Patients: Are These Markers of Aggressive Behavior and Metastatic Potential?

  2003cites this paper
• Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination.

  2003cites this paper
• Sentinel lymph node versus axillary lymph node dissection for early‐stage breast carcinoma

  2003cites this paper
• Ethnicity related differences in the survival of young breast carcinoma patients

  2002cites this paper
• Una nueva concepción de los cuidados paliativos en Oncología: los cuidados continuos y la integración de niveles

  2002cites this paper
• Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.

  2002cites this paper
• Impact of Delay on Diagnosis and Treatment of Primary Lung Cancer

  2002cites this paper
• Gene Expression Patterns in Breast Cancer May Identify Specific Tumor Phenotypes and Predict Disease Outcome

  2002cites this paper
• 20 Immunohistochemical expression of raf kinase inhibitor protein in prostate carcinoma

  2002cites this paper
• Biomarcadores en el pronóstico y respuesta al tratamiento en cáncer mamario

  2002cites this paper
• Mammographically Detected Breast Cancers and the Risk of Axillary Lymph Node Involvement: Is It Just the Tumor Size?

  2002cites this paper
• Paclitaxel in the adjuvant setting: results so far are inconclusive.

  2001cites this paper